NCT02246374View on ClinicalTrials.gov

ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Parkinson's Disease
Interventions
DEVICE

ExAblate Transcranial System

ExAblate Transcranial System subthalamotomy for symptoms of Parkinson's Disease

Trial Locations (1)

22908

University of Virginia, Charlottesville

Sponsors

Lead Sponsor

InSightec
All Listed Sponsors
lead

InSightec

INDUSTRY